T. Rowe Price reports 5.1% stake in Encompass Health

T. Rowe Price Associates, Inc. reports beneficial ownership of 5,056,225 shares of Encompass Health Corp common stock, representing 5.1% of the class.

Rhea-AI Filing Summary

T. Rowe Price Associates, Inc. reports beneficial ownership of 5,056,225 shares of Encompass Health Corp common stock, representing 5.1% of the class. The firm reports sole voting power over 4,897,333 shares and sole dispositive power over 5,056,225 shares, with no shared voting or dispositive power.

T. Rowe Price Associates states that this report should not be construed as an admission that it is the beneficial owner of these securities and expressly denies such beneficial ownership.

Key Figures

Shares beneficially owned: 5,056,225 shares Percent of class: 5.1% Sole voting power: 4,897,333 shares +3 more

6 metrics

Shares beneficially owned 5,056,225 shares Encompass Health Corp common stock reported by T. Rowe Price Associates

Percent of class 5.1% Portion of Encompass Health Corp common stock class held by T. Rowe Price Associates

Sole voting power 4,897,333 shares Shares of Encompass Health Corp over which T. Rowe Price Associates has sole voting power

Shared voting power 0 shares Shares of Encompass Health Corp with shared voting power reported

Sole dispositive power 5,056,225 shares Shares of Encompass Health Corp over which T. Rowe Price Associates has sole dispositive power

Shared dispositive power 0 shares Shares of Encompass Health Corp with shared dispositive power reported

Key Terms

Schedule 13G, beneficial owner, sole voting power, sole dispositive power

4 terms

Schedule 13G regulatory

"T. Rowe Price Associates filed a Schedule 13G reporting its beneficial ownership position"

A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.

beneficial owner regulatory

"shall not be construed as an admission that Price Associates is the beneficial owner"

A beneficial owner is the person who ultimately owns or controls a financial asset or property, even if their name isn't directly on official documents. Think of it like someone who secretly holds the keys to a safe deposit box—others may appear to have access, but the true owner is the one who benefits from what's inside. Identifying beneficial owners helps ensure transparency and prevent illegal activities like money laundering or fraud.

sole voting power financial

"Sole voting power 4,897,333.00"

Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.

sole dispositive power financial

"Sole dispositive power 5,056,225.00"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What percentage of Encompass Health Corp (EHC) does T. Rowe Price Associates own?

T. Rowe Price Associates reports beneficial ownership of 5.1% of Encompass Health Corp common stock, representing 5,056,225 shares. This ownership is reported on a Schedule 13G as a significant institutional holding.

How many Encompass Health Corp (EHC) shares can T. Rowe Price Associates vote?

T. Rowe Price Associates reports sole voting power over 4,897,333 shares of Encompass Health Corp and no shared voting power. Voting power reflects how many shares the firm can vote or direct the vote for.

What is T. Rowe Price Associates’ dispositive power over Encompass Health Corp (EHC) shares?

The firm reports sole dispositive power over 5,056,225 shares of Encompass Health Corp and no shared dispositive power. Dispositive power refers to the authority to sell or otherwise dispose of the shares.

Does T. Rowe Price Associates admit beneficial ownership of Encompass Health Corp (EHC) shares?

No. T. Rowe Price Associates states that this Schedule 13G filing shall not be construed as an admission that it is the beneficial owner of the securities and that such beneficial ownership is expressly denied.

What type of filing did T. Rowe Price Associates make regarding Encompass Health Corp (EHC)?

T. Rowe Price Associates filed a Schedule 13G reporting its beneficial ownership position in Encompass Health Corp common stock. Schedule 13G is typically used by certain institutional investors for passive ownership reporting.

Where is T. Rowe Price Associates, which holds Encompass Health Corp (EHC) shares, organized?

T. Rowe Price Associates identifies its citizenship or place of organization as Maryland. This information appears in the Schedule 13G along with its reported ownership percentages and share counts in Encompass Health Corp.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/14/2026 - 10:39 AM Accepted by SEC EDGAR 08/14/2026 - 10:38 AM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

ENCOMPASS HEALTH CORP

(Name of Issuer)

COMMON STOCK

(Title of Class of Securities)

29261A100

(CUSIP Number)

06/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 29261A100

1

Names of Reporting Persons

T. Rowe Price Associates, Inc.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

MARYLAND

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 4,897,333.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 5,056,225.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

5,056,225.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.1 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

Item 1.
(a)	Name of issuer: ENCOMPASS HEALTH CORP
(b)	Address of issuer's principal executive offices: 100 VANGUARD BLVD, MALVERN, PA, 19355
Item 2.
(a)	Name of person filing: T. Rowe Price Associates, Inc.
(b)	Address or principal business office or, if none, residence: 1307 Point Street, Baltimore, MD 21231
(c)	Citizenship: Maryland
(d)	Title of class of securities: COMMON STOCK
(e)	CUSIP Number(s): 29261A100
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 5056225
(b)	Percent of class: 5.1 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 4897333
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 5056225
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. T. Rowe Price Associates, Inc. hereby declares and affirms that the filing of Schedule 13G shall not be construed as an admission that Price Associates is the beneficial owner of the securities referred to, which beneficial ownership is expressly denied.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

T. Rowe Price Associates, Inc.

Signature:	Ellen York
Name/Title:	Vice President
Date:	08/14/2026